PanTheryx Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PanTheryx Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10885
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PanTheryx Inc (PanTheryx) is a medical nutrition company that research, develops and commercializes nutritional ingredients. The company’s products include foods for special dietary use, dietary supplements and medical foods. Its foods for special dietary use address the dietary needs of children with infectious diarrhea. PanTheryx’s dietary supplements are used by a healthy, non-diseased population to support intestinal health. The company’s medical foods are used for the dietary management of people with special medically-determined nutrient requirements. PanTheryx is headquartered in Boulder, Colorado, the US.

PanTheryx Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PanTheryx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PanTheryx Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PanTheryx Raises USD8.9 Million in Financing 10
PanTheryx Raises Additional USD0.6 Million in Venture Financing 11
PanTheryx Raises Additional USD0.08 Million in Venture Financing 12
PanTheryx Raises Additional USD2.91 Million in Venture Financing 13
PanTheryx Raises US$1.4 Million In Venture Financing 14
PanTheryx Raises US$3.5 Million In Venture Financing 15
Private Equity 16
Pegasus Capital Invests USD53 Million in PanTheryx 16
Licensing Agreements 17
Dr. Reddy’s Labs Enters into Licensing Agreement with PanTheryx for DiaResQ 17
PanTheryx Inc – Key Competitors 18
PanTheryx Inc – Key Employees 19
PanTheryx Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
PanTheryx Inc, Pharmaceuticals & Healthcare, Key Facts 2
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PanTheryx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PanTheryx Inc, Deals By Therapy Area, 2012 to YTD 2018 8
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PanTheryx Raises USD8.9 Million in Financing 10
PanTheryx Raises Additional USD0.6 Million in Venture Financing 11
PanTheryx Raises Additional USD0.08 Million in Venture Financing 12
PanTheryx Raises Additional USD2.91 Million in Venture Financing 13
PanTheryx Raises US$1.4 Million In Venture Financing 14
PanTheryx Raises US$3.5 Million In Venture Financing 15
Pegasus Capital Invests USD53 Million in PanTheryx 16
Dr. Reddy’s Labs Enters into Licensing Agreement with PanTheryx for DiaResQ 17
PanTheryx Inc, Key Competitors 18
PanTheryx Inc, Key Employees 19
PanTheryx Inc, Subsidiaries 20

List of Figures
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PanTheryx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[PanTheryx Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Barkan Wine Cellars Ltd:企業の戦略的SWOT分析
    Barkan Wine Cellars Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Aviragen Therapeutics Inc (AVIR):企業の財務・戦略的SWOT分析
    Aviragen Therapeutics Inc (AVIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Bangkok Chain Hospital Public Co Ltd (BCH):企業の財務・戦略的SWOT分析
    Bangkok Chain Hospital Public Co Ltd (BCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Regions Financial Corporation:戦略・SWOT・企業財務分析
    Regions Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Regions Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Dedeman Hotels & Resorts International:企業の戦略・SWOT・財務情報
    Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report Summary Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Pioneer Distilleries Limited:企業の戦略・SWOT・財務情報
    Pioneer Distilleries Limited - Strategy, SWOT and Corporate Finance Report Summary Pioneer Distilleries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • IntriCon Corp (IIN):医療機器:M&Aディール及び事業提携情報
    Summary IntriCon Corp (IntriCon) is a designer, developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products. The company’s products comprise glucose monitoring, medical coils, cardiac monitoring, amplifiers, systems, plastic medical molding, support product …
  • VWR International LLC:医療機器:M&Aディール及び事業提携情報
    Summary VWR International LLC (VWR), a subsidiary of Avantor Performance Materials Inc, is a provider of product and service solutions to laboratory and production companies. The company offers products such as adhesive dispensers, adhesive labels, adhesive slides, agarose and acrylamide, air freshe …
  • Kennametal Inc.:企業の戦略・SWOT・財務情報
    Kennametal Inc. - Strategy, SWOT and Corporate Finance Report Summary Kennametal Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • NaviNet Inc:企業の戦略的SWOT分析
    NaviNet Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Somnomed Ltd (SOM):企業の財務・戦略的SWOT分析
    Summary Somnomed Ltd (SomnoMed) is a medical device company that develops, produces, commercializes and markets devices for the oral treatment of sleep-related disorders. The company’s products include Somnodent, an oral appliance for obstructive sleep apnea; and Somnobrux, a mouthguard that protect …
  • Ornim Inc-医療機器分野:企業M&A・提携分析
    Summary Ornim Inc (Ornim) is a medical device company that specializes in clinical research, development, and distribution of medical devices in the field of tissue and cerebral blood flow and perfusion. The company’s c-FLOW is a continuous non-invasive monitor of deep tissue blood flow that is used …
  • Hill International, Inc. (HIL):企業の財務・戦略的SWOT分析
    Hill International, Inc. (HIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Twist Bioscience Corp (TWST):医療機器:M&Aディール及び事業提携情報
    Summary Twist Bioscience Corp (Twist Bioscience) is a provider of synthetic DNA Tools. Its silicon-based DNA synthesis platform enables precise synthesis and sequencing process and production of synthetic DNA tools. The company offers its products which include DNA tools for gRNA cloning such as una …
  • Confused.Com Limited:企業の戦略・SWOT・財務分析
    Confused.Com Limited - Strategy, SWOT and Corporate Finance Report Summary Confused.Com Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mutual Trust Bank Limited:企業の戦略・SWOT・財務情報
    Mutual Trust Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Mutual Trust Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Codexis Inc (CDXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Codexis Inc (Codexis) is a protein engineering company, which develops proteins for a wide range of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, industrial enzymes and fine chemicals, and enzymes as biotherapeutics and for use in molecular diagno …
  • LG Chem Ltd (051910):電力:M&Aディール及び事業提携情報
    Summary LG Chem Ltd (LG Chem) is a chemical manufacturer. It manufactures and markets petrochemicals, IT and electronic materials, and energy solutions. The company’s product portfolio comprises poly vinyl chloride (PVC), ethylene, propylene, butadiene, benzene, polarizer, glass substrate, semicondu …
  • Jaiprakash Associates Ltd (JPASSOCIAT):電力:M&Aディール及び事業提携情報
    Summary Jaiprakash Associates Limited (JAL) is a diversified infrastructure conglomerate. The company manufactures and sales cement, clinker, and cement products; develops and manages hotels, golf course, resorts and spa; develops real estate; and constructs sports infrastructure and expressways. Th …
  • Cummins Inc (CMI):企業の財務・戦略的SWOT分析
    Cummins Inc (CMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆